Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
| 131.28 Delayed Data As of 4:00pm ET |  -4.35 / -3.21%Today’s Change | 117.64 Today|||52-Week Range 189.00 | +3.05% Year-to-Date |
Latest JAZZ News | Press Releases
| Zogenix (ZGNX) Stock Surges on Acquisition Offer From UCB Jan 20 / Zacks.com - Paid Partner Content | 2 Stocks to Buy No Matter What Happens in 2022 Jan 14 / MotleyFool.com - Paid Partner Content |
| Can Jazz (JAZZ) Climb 41% to Reach the Level Wall Street Analysts Expect? Jan 17 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 135.63 |
| Today’s open | 133.66 |
| Day’s range | 129.79 - 133.82 |
| Volume | 24,868 |
| Average volume (3 months) | 635,767 |
| Market cap | $8.4B |
Data as of 4:00pm ET, 01/25/2022
Growth & Valuation
| Earnings growth (last year) | -53.56% |
| Earnings growth (this year) | +25.97% |
| Earnings growth (next 5 years) | +11.30% |
| Revenue growth (last year) | +9.34% |
| P/E ratio | NM |
| Price/Sales | 3.95 |
| Price/Book | 2.10 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BHCValeant Pharmaceutic... | -0.29 | -1.18% |
| BHVNBiohaven Pharmaceuti... | -2.46 | -2.07% |
| UTHRUnited Therapeutics ... | -2.88 | -1.42% |
| EVOEvotec SE | -0.40 | -2.01% |
Data as of 4:00pm ET, 01/25/2022
Financials
| Next reporting date | March 1, 2022 |
| EPS forecast (this quarter) | $3.68 |
| Annual revenue (last year) | $2.4B |
| Annual profit (last year) | $238.6M |
| Net profit margin | 10.10% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
